analyst
RL
NASDAQ · RLAY
Relay Therapeutics, Inc.
Healthcare · Biotechnology
$18.03
Down-$0.30 (-1.66%)
Updated Sep 25, 2026, 1:31 AM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.35B
- P/E ratio
- -4.52
- Dividend yield
- 0.00%
- 52-week range
- $9.27 – $21.27
- Volume
- 4.71M
- Avg. volume
- 1.93M
Price performance
RLAY price history
1M range · 20 trading sessions · Daily adjusted prices
RLAY closed at $17.73 after 20 trading sessions, down 8.70% for the selected period.
- Last close
- $17.73
- Period change
- -8.70%
- Period low
- $17.73
- Period high
- $19.42
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | $18.09 | $18.09 | $17.41 | $17.73 | 3.68M |
| Sep 23, 2026 | $19.15 | $19.23 | $17.22 | $18.03 | 4.71M |
| Sep 22, 2026 | $18.43 | $19.48 | $18.2125 | $19.35 | 3.63M |
| Sep 21, 2026 | $19.07 | $19.17 | $18.05 | $18.19 | 3.03M |
| Sep 18, 2026 | $19.25 | $19.40 | $18.68 | $18.84 | 10.08M |
| Sep 17, 2026 | $19.45 | $19.69 | $19.065 | $19.19 | 3.1M |
| Sep 16, 2026 | $18.97 | $19.2199 | $18.62 | $18.84 | 2.12M |
| Sep 15, 2026 | $19.05 | $19.09 | $18.64 | $18.97 | 2.74M |
| Sep 14, 2026 | $18.90 | $19.43 | $18.88 | $19.06 | 2.4M |
| Sep 11, 2026 | $19.17 | $19.35 | $18.675 | $18.87 | 4.16M |
| Sep 10, 2026 | $18.30 | $19.11 | $18.10 | $18.89 | 3M |
| Sep 9, 2026 | $18.76 | $19.185 | $18.54 | $18.66 | 6.06M |
| Sep 8, 2026 | $18.775 | $19.28 | $18.3141 | $19.11 | 5.03M |
| Sep 4, 2026 | $18.85 | $19.2569 | $18.68 | $19.04 | 2.05M |
| Sep 3, 2026 | $18.55 | $19.10 | $18.34 | $19.01 | 2.72M |
| Sep 2, 2026 | $18.70 | $19.27 | $18.29 | $18.51 | 2.11M |
| Sep 1, 2026 | $18.15 | $18.68 | $17.96 | $18.49 | 1.6M |
| Aug 31, 2026 | $18.54 | $18.64 | $18.03 | $18.38 | 3.78M |
| Aug 28, 2026 | $19.15 | $19.30 | $18.63 | $18.77 | 2.76M |
| Aug 27, 2026 | $19.23 | $19.68 | $19.16 | $19.42 | 2.39M |
Latest RLAY news
The latest Smart Investors Daily articles mentioning RLAY.
Stock researchCompany · Forecast
Loading stock research…